SEBI Reg. Investment Advisor

Download App
Help Center Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Influx Healthtech Ltd (INFLUX)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: INFLUX Pharmaceuticals & Drugs | Small Cap | Influx Healthtech Share Price

BSE Share Price
Not Listed

Influx Healthtech Ltd (INFLUX)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: INFLUX Pharmaceuticals & Drugs | Small Cap | Influx Healthtech Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹568 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹8.9
TTM Sales
₹147 Cr.
Book Value per Share
₹17.8
P/E Ratio
27.67
Lower than its 5-year historical median
Industry PE
48.5
Price to Book (P/B)
13.81
Higher than its 5-year historical median
Price to Sales (P/S)
3.87
Lower than its 5-year historical median
EV/EBITDA
18.16
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
45.37%
Outperforms industry median
Return on Capital Employed (ROCE)
60.15%
Outperforms industry median
Return on Assets (ROA)
24.10%
Operating Profit Margin
19.6%
Net Profit Margin
12.75%
Gross Profit Margin
19.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
4.88%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
21.34%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
20.13%
Asset Quality
Promoter Holding
73.53%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹18 Cr.
Equity
₹23.2 Cr.
Face Value
₹10
All Time Low / High
- / -

Influx Healthtech stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Influx Healthtech Ltd a good quality company?
Influx Healthtech Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Influx Healthtech Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Influx Healthtech Ltd vs industry peers?
Influx Healthtech Ltd revenue CAGR is 20.99%, compared to the industry median CAGR of 6.81%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Influx Healthtech Ltd?
Promoters hold 73.53% of the Influx Healthtech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Influx Healthtech Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Influx Healthtech Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation ⓘ

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ119.4%111.9%85.3%60.2%-
Value Creation
Index ⓘ		7.57.05.13.3-

Growth Parameters ⓘ
Sales ⓘ59.276.1100105147
Sales YoY Gr.-28.5%31.4%4.9%-
Adj EPS ⓘ2.546.17.48.9
YoY Gr.-61.6%54.8%20.2%-
BVPS (₹) ⓘ2.56.412.619.917.8
Adj Net
Profit ⓘ		4.47.211.113.421
Cash Flow from Ops. ⓘ2.96.48.97.1-
Debt/CF from Ops. ⓘ0.20.100-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANA21%4.9%
Adj EPS ⓘNANA44.4%20.2%
BVPSⓘNANA100.8%58.7%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		99.689.364.645.447.1
Op. Profit
Mgn % ⓘ		10.414.11719.6NAN
Net Profit
Mgn % ⓘ		7.59.511.112.814
Debt to
Equity ⓘ		0.10.100-
Working Cap
Days ⓘ		076771270
Cash Conv.
Cycle ⓘ		0-37220

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales5976100105
Operating Expenses ⓘ + 53658384
Manufacturing Costs13172328
Material Costs35404843
Employee Cost 3568
Other Costs ⓘ 2455
Operating Profit ⓘ 6111721
Operating Profit Margin (%) 10.4%14.1%17.0%19.6%
Other Income ⓘ + 0000
Exceptional Items ⓘ 0000
Interest ⓘ 0000
Depreciation ⓘ 0123
Profit Before Tax ⓘ 6101518
Tax ⓘ 2345
Profit After Tax 471113
PAT Margin (%) 7.5%9.5%11.1%12.8%
Adjusted EPS (₹)2.44.06.17.4
Dividend Payout Ratio (%)0%0%0%0%

Valuation of Influx Healthtech - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 4122336
Share Capital ⓘ 00018
Reserves ⓘ 4122318
Debt +1100
Long Term Debt0000
Short Term Debt0100
Minority Interest0000
Trade Payables11131429
Others Liabilities ⓘ 2244
Total Liabilities ⓘ 18284170

Fixed Assets

Net Fixed Assets ⓘ +361419
Gross Block371725
Accumulated Depreciation0136
CWIP ⓘ 0000
Investments ⓘ 0000
Inventories22513
Trade Receivables10141632
Cash Equivalents 1442
Others Assets ⓘ 1324
Total Assets ⓘ 18284170

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 3697
PBT ⓘ 6101518
Adjustment ⓘ 0123
Changes in Working Capital ⓘ -2-2-5-9
Tax Paid ⓘ -1-3-3-4
Cash Flow From Investing Activity ⓘ + -3-5-8-9
Capex -3-5-8-8
Net Investments 000-1
Others ⓘ 0000
Cash Flow From Financing Activity ⓘ + 10-1-0
Net Proceeds from Shares ⓘ 0000
Net Proceeds from Borrowing ⓘ 1-0-00
Interest Paid ⓘ -0-0-0-0
Dividend Paid ⓘ 0000
Others ⓘ 10-0-0
Net Cash Flow ⓘ 120-2

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)99.5489.3264.6445.37
ROCE (%)119.35111.8585.2660.15
Asset Turnover Ratio3.373.312.891.89
PAT to CFO Conversion(x)0.750.860.820.54
Working Capital Days
Receivable Days63.6057.9054.3084.20
Inventory Days10.808.9013.5032.50
Payable Days113.80112103.80183.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Influx Healthtech Ltd FAQs

The current trading price of Influx Healthtech on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Influx Healthtech stood at ₹568.3 Cr

The latest P/E ratio of Influx Healthtech as of 31-Dec-1969 is 27.67.

The latest P/B ratio of Influx Healthtech as of 31-Dec-1969 is 13.81.

The 52-week high of Influx Healthtech is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Influx Healthtech is ₹147 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Influx Healthtech Ltd is a average quality company.

The key valuation ratios of Influx Healthtech Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Influx Healthtech Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Influx Healthtech Ltd

Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as ‘Influx Healthtech Private Limited’ under the provisions of the Companies Act, 2013 with the Registrar of Companies, Central Registration Centre. Pursuant to a special resolution passed by the shareholders at their Extra Ordinary General Meeting held on May 09, 2022, the company was converted from a Private Limited Company to Public Limited Company. Consequently, the name of the company was changed to ‘Influx Healthtech Limited’ and a Fresh Certificate of Incorporation consequent to Conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai.

Influx Healthtech is a Mumbai-based, healthcare focused company specialising in contract manufacturing. Since its inception in 2020, the company has established as a reliable Contract Development and Manufacturing Organization (CDMO), offering specialized services to a wide range of clients across various industries. The company operates manufacturing facilities located in Thane, Maharashtra. These facilities are certified to international quality standards, including GMP (Good Manufacturing Practice), HACCP (Hazard Analysis & Critical Control Points), ISO 22000, and Halal certifications, ensuring adherence to the highest standards of safety,quality and regulatory compliance. These certifications reflect its adherence to stringent safety, quality, and regulatory compliance standards. Equipped with advanced machinery, a dedicated quality control department, and a skilled workforce, its facilities are designed to meet diverse customer needs efficiently and effectively.

Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables.

Business area of the company

The company is engaged in the business of manufacturing and trading of Nutra Products and other related business activities.

Products of the company

  • Dietary/Nutritional SUPPLEMENTS
  • Cosmetics
  • Ayurvedic / Herbal
  • Veterinary feeds
  • Homecare

Awards and recognition

  • 2017: Rotary Vocation Excellence Award 2017-18.
  • 2017: Best Third-Party Manufacturing company sports and Nutrition.
  • 2018: Most Promising Nutraceutical and Herbal Products Manufacture.
  • 2018: Most Promising Nutraceutical and Herbal Product Manufacturer of the year 
  • 2019: Best Nutaceutical Manufacturer to Dr. Munir Chandniwala, Managing Director of the Company.
  • 2023: Best Rotarian of the year 22-23.

History and milestones

  • 2020: Incorporation of the Company as a Private Limited Company with the name of ‘Influx Healthtech Private Limited’.
  • 2021: Addition in Main Object of a new segment of beauty and cosmetics products, personal care and disinfectant products.
  • 2022: Converted to Public Limited Company – consequently the name of the company was changed to ‘Influx Healthtech Limited’.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: